期刊文献+

罗格列酮提高胰岛素抵抗大鼠大网膜脂肪细胞PPAR-γmRNA的表达水平 被引量:1

Experimental study of Rosiglitazone tablets effect on PPAR-γmRNA's expression of greater omental adipocyte in IR rats
下载PDF
导出
摘要 目的观察胰岛素抵抗(IR)大鼠大网膜脂肪细胞过氧化物酶体增生物激活受体γ(PPAR-γ)mRNA的表达水平以及罗格列酮对PPAR-γmRNA表达水平的影响。方法雄性Wistar大鼠随机分为空白组、模型组、罗格列酮组,正常组喂以普通饲料,模型组与治疗组注射小剂量STZ并喂以高热量饲料,常规测定各组大鼠治疗前后的空腹血糖(FPG)和治疗后各组大鼠的空腹血清胰岛素水平(FIns),计算胰岛素敏感性指数(ISI),测定各组血脂水平,提取大网膜脂肪组织总RNA,采用逆转录PCR技术扩增PPAR-γ基因片段,检测其表达水平。结果模型组PPAR-γmRNA表达比正常组明显减少(P<0.01),与模型组比较,罗格列酮组PPAR-γmRNA表达显著增加(P<0.01)。结论R大鼠脂肪细胞PPAR-γmRNA表达减少,而罗格列酮能有效提高PPAR-γmRNA的表达。 Objective To investigate the difference of peroxisome proliferator-activated receptor--γ(PPAR-T)mRNA's expression in greater omental adipose in insulin resistance(IR) rats and Rosiglitazone Tablets'effect on it. Methods Male wistar rats were randomly divided into 3 groups (normal group, model group, Rosiglitazone Tablets treating group). The rats of normal group were fed with common food while the others with high calorie food and injected with low dose of STZ. Fasting plasma glucose(FPG) level, fasting insulin (Fins) level and blood fat of all rats were measured by routine methods,and insulin sensitivity index(ISI) was calculated accordingly. At the end of experimental treatment, the total mRNAs of greater omental adipose tissues were extracted and the genie fragments of PPAR-γwere amplificated in order to detect their expression levels. Results Rosiglitazone tablets could reduce FPG and Fins level in model rats and enhance ISI effectively.The PPAR-γmRNAs were expressed less obviously in the rats of model group than in normal group (P〈0.01). The expressional level was significantly higher in Rosiglitszone tablets treating group than model group (P〈0.01). Conclusion The PPAB-γmBNAs are expressed less obviously in IR rats,and Rosiglitazone maleate tablets can enhance its genie expressional level effectively.
出处 《江西医药》 CAS 2006年第11期847-850,共4页 Jiangxi Medical Journal
关键词 胰岛素抵抗 罗格列酮 PPAR-Γ insulin resistance Rosiglitazone tablets PPAR-γ
  • 相关文献

参考文献5

  • 1司晓晨,尚文斌,卞慧敏,程海波.链脲佐菌素加高脂膳食诱导2型糖尿病大鼠模型[J].安徽中医临床杂志,2003,15(5):383-385. 被引量:84
  • 2李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 3Rosen ED,Spiegelman BM.PPARgamma:a nuclear regulator of metabolism,differentiation,and cell growth.J Biol Chem,2001,276:37731
  • 4Lefebvre AM,Laville M,Vega N,et al.Depot-specific differences in adipose tissue gene expression in lean and obese subjects.Diabetes,1998,47:98
  • 5Schinner S,Dellas C,Schreder M,et al.Repression of Glucagon Gene Transcription by Peroxisome Proliferator-activated Receptor gamma through Inhibition of Pax6 Transcriptional Activity,J Biol Chem,2002,277:1941

二级参考文献8

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balancedoverview. Diabetes Care, 1992,15:318~368.
  • 3Storlien LH, James DE, Burleigh KM, et al. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol 1986,251: E576~83.
  • 4DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol 1979,237(3):E214.
  • 5Goto Y, Kakizaki. The spontaneous--diabetes rat: a model of noninsulin dependent diabetes mellitus. Proc Japan Acad,1981 . 381~384.
  • 6Matthael S, Stumvoll M, Kellerer M, et al . Pathophysiology and Pharmacological treatment of insulin resistance.Endocrine review , 2000,21 : 585~ 618.
  • 7蔡文就,熊曼琪,朱章志,林安钟,郑高飞,贾可亮,陈芝喜,沈穗婷,何敏.实验性NIDDM大鼠模型及其胰岛素抵抗的初步研究[J].广州中医药大学学报,1997,14(2):87-91. 被引量:48
  • 8李晨钟.胰岛素抵抗的动物模型[J].国外医学(内分泌学分册),1998,18(3):144-147. 被引量:20

共引文献2191

同被引文献14

  • 1李勇,刘孟宇,王颜刚.生芪降糖颗粒对胰岛素抵抗鼠的作用及机制研究[J].中国中西医结合杂志,2007,27(5):449-451. 被引量:8
  • 2郝玉美,刘洪琪.苦瓜 黄芪 黄芩苷对2型糖尿病大鼠模型胰岛素抵抗的影响[J].辽宁中医药大学学报,2007,9(5):6-7. 被引量:17
  • 3Shulman G 1. Cellular mechanisms of insulin resistance [J]. J Clin Invest, 2000,106:171.
  • 4Hanley A J, Williams K, Gonzalez C, et al. Prediction of type 2 diabetes using simple measures of insulin resistance:combined results from the san antonio heart study, the mexico city diabetes study, and the insulin resistance atherosclerosis study [ J ]. Diabetes, 2003, 52:463.
  • 5Cahova' M, Vavrinkova' H, Kazdova' L. Glucose-fatty acid interaction in skeletal muscle and adipose tissue in insulin resistance[ J]. Physiol Res,2007, 56 : 1.
  • 6Kim J Y, Van de Wall E, Laplante M, et al. Obesityassociated improvements in metabolic profile through expansion of adipose tissue [ J]. J Clin Invest, 2007, 117:2621.
  • 7Eldor R, Raz I. Lipotoxicity versus adipotoxicity-the deleterious effects of adipose tissue on beta cells in the pathogenesis of type 2 diabetes [ J]. Diabetes Res Clin Pract, 2006,74s : s3.
  • 8Nakao K. Adiposcience and adipotoxicity[ J]. Nat Clin Pract Endoc Metab, 2009, 5(2) :63.
  • 9Kershaw E E,Fliter J S. Adipose tissue as an endocrine organ [ J ]. J Clin Endocrinol Metab ,2004 ,89 ( 6 ) :2548.
  • 10Kolaczyski J W, Nyce M R, Considine R V, et al. Acute and insulin on leptin production in humans: studies in vivo and chronic effects of in vitro[ J]. Diabetes, 1996, 45 : 699.

引证文献1

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部